These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

786 related items for PubMed ID: 15297056

  • 1. Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine.
    Isaka M, Komiya T, Takahashi M, Yasuda Y, Taniguchi T, Zhao Y, Matano K, Matsui H, Maeyama J, Morokuma K, Ohkuma K, Goto N, Tochikubo K.
    Vaccine; 2004 Aug 13; 22(23-24):3061-8. PubMed ID: 15297056
    [Abstract] [Full Text] [Related]

  • 2. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M, Yasuda Y, Taniguchi T, Kozuka S, Matano K, Maeyama J, Morokuma K, Ohkuma K, Goto N, Tochikubo K.
    Vaccine; 2003 Mar 07; 21(11-12):1165-73. PubMed ID: 12559794
    [Abstract] [Full Text] [Related]

  • 3. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.
    Virology; 2008 Oct 25; 380(2):412-20. PubMed ID: 18786689
    [Abstract] [Full Text] [Related]

  • 4. Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice.
    Isaka M, Zhao Y, Nobusawa E, Nakajima S, Nakajima K, Yasuda Y, Matsui H, Hasegawa T, Maeyama J, Morokuma K, Ohkuma K, Tochikubo K.
    Microbiol Immunol; 2008 Feb 25; 52(2):55-63. PubMed ID: 18380802
    [Abstract] [Full Text] [Related]

  • 5. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit.
    Takahashi Y, Kumada H, Hamada N, Haishima Y, Ozono S, Isaka M, Yasuda Y, Tochikubo K, Umemoto T.
    Oral Microbiol Immunol; 2007 Dec 25; 22(6):374-80. PubMed ID: 17949339
    [Abstract] [Full Text] [Related]

  • 6. Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant.
    Isaka M, Yasuda Y, Mizokami M, Kozuka S, Taniguchi T, Matano K, Maeyama J, Mizuno K, Morokuma K, Ohkuma K, Goto N, Tochikubo K.
    Vaccine; 2001 Jan 08; 19(11-12):1460-6. PubMed ID: 11163669
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit.
    Isaka M, Yasuda Y, Kozuka S, Miura Y, Taniguchi T, Matano K, Goto N, Tochikubo K.
    Vaccine; 1998 Oct 08; 16(17):1620-6. PubMed ID: 9713937
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
    Trollfors B, Taranger J, Lagergård T, Sundh V, Bryla DA, Schneerson R, Robbins JB.
    Clin Infect Dis; 1999 Mar 08; 28(3):552-9. PubMed ID: 10194077
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Development studies of lyophilized standard diphtheria-tetanus-pertussis vaccines].
    Ozcengiz E, Unver D, Cayan HH, Atakan Ablay P, Kanik E.
    Mikrobiyol Bul; 2007 Apr 08; 41(2):165-73. PubMed ID: 17682702
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oral vaccination against Helicobacter pylori with recombinant cholera toxin B-subunit.
    Kubota E, Joh T, Tanida S, Sasaki M, Kataoka H, Watanabe K, Itoh K, Oshima T, Ogasawara N, Togawa S, Wada T, Yamada T, Mori Y, Fujita F, Shimura T, Ohara H, Isaka M, Yasuda Y, Itoh M.
    Helicobacter; 2005 Aug 08; 10(4):345-52. PubMed ID: 16104951
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1/Th2 immune response in diphtheria-tetanus-pertussis vaccine.
    Sugai T, Mori M, Nakazawa M, Ichino M, Naruto T, Kobayashi N, Kobayashi Y, Minami M, Yokota S.
    Vaccine; 2005 Nov 16; 23(46-47):5450-6. PubMed ID: 16006019
    [Abstract] [Full Text] [Related]

  • 20. Mucosal immunisation of murine neonates using whole cell and acellular Pertussis vaccines.
    Hale C, Humphreys IR, Hussell T, Bowe F, Clare S, Pickard D, Preston A, Del Giudice G, Dougan G.
    Vaccine; 2004 Sep 09; 22(27-28):3595-602. PubMed ID: 15315838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.